Infant Formula Oligosaccharide Blend for Intestinal Barrier Maturation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infant formulas fail to adequately replicate the beneficial effects of human milk on intestinal health and immune system development, particularly in terms of intestinal barrier function and pathogen defense.
Innovation Solution
A nutritional composition combining 2'-fucosyllactose (2'FL) and 3'-galactosyllactose (3'GL), along with dietary butyric acid, which is fermented by lactic acid-producing bacteria, to enhance intestinal barrier function and immune system response, thereby improving defense against pathogens and promoting a healthy gut microbiota.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If infant formula uses conventional composition, then manufacturing is simple and cost-effective, but intestinal barrier function and pathogen defense are insufficient
Solution Approach 1:
The patent combines multiple specific oligosaccharides (2'-FL, 3'-GL, 6'-SL) with defined ratios into a composite prebiotic mixture, merging their individual benefits for intestinal barrier function, microbiota modulation, and pathogen defense into a single integrated nutritional composition that replicates human milk's protective effects
Solution Approach 2:
The invention creates a composite nutritional material comprising proteins, carbohydrates, fats, vitamins, minerals, and specifically formulated oligosaccharide blends (including 2'-FL, 3'-GL, 6'-SL) that work synergistically to improve intestinal health and immune function, moving beyond simple ingredient lists to functionally integrated formulations
2Reliability
If infant formula includes multiple oligosaccharides, then intestinal health improves, but manufacturing precision requirements increase
Solution Approach 1:
The patent specifies precise compositional parameters for oligosaccharides including 2'-fucosyllactose (2'-FL), 3'-galactosyllactose (3'-GL), and 6'-sialyllactose (6'-SL) with defined concentration ranges and ratios, transforming the manufacturing challenge into a controlled parameter specification that ensures consistent physiological effects while allowing flexible production
Solution Approach 2:
The invention copies the oligosaccharide profile found in human milk, replicating its protective functions against pathogens and its role in intestinal barrier maturation through synthesized or extracted oligosaccharide blends that mirror natural human milk composition without requiring identical complexity
3Reliability
If human milk is used, then optimal intestinal maturation and immune protection are achieved, but breastfeeding is not always possible or desirable
Solution Approach 1:
The patent extracts and isolates the key protective components from human milk—specifically oligosaccharides like 2'-FL, 3'-GL, and 6'-SL, along with selected proteins and fatty acids—into a concentrated formulation that can be delivered through formula, separating the beneficial functions from the biological matrix of human milk to enable versatile delivery options
Solution Approach 2:
The invention creates a universal infant formula composition that replicates multiple functions of human milk simultaneously: providing nutrition, supporting intestinal barrier maturation, modulating microbiota, and offering pathogen defense through incorporated oligosaccharides and bioactive compounds, making it suitable for all infants regardless of breastfeeding availability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of 2'FL, 3'GL, and butyric acid in the nutritional composition significantly improves intestinal barrier maturation, immune system function, and microbiota health, providing enhanced protection against infections and allergies.
Implementation Method 1
A nutritional composition combining 2'-fucosyllactose (2'FL) and 3'-galactosyllactose (3'GL), along with dietary butyric acid, which is fermented by lactic acid-producing bacteria
Data Source
Figure 1A~1B
Figure 1C~1D
Figure 2
AI summary
The invention pertains to a nutritional composition for infants or young children comprising 2'fucosyllactose, and 3'galactosyllactose, and preferably dietary butyric acid.